Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO01094) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
13-cis-retinal
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Preclinical/Patented Drug
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=6436079"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Induced by This Xenobiotics | ||||||
| Cytochrome P450 3A4 (CYP3A4) | DME Info | Homo sapiens | [1] | |||
| References | ||||||
| 1 | Retinoids activate the RXR/SXR-mediated pathway and induce the endogenous CYP3A4 activity in Huh7 human hepatoma cells. Toxicol Sci. 2006 Jul;92(1):51-60. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.